Berenberg analyst Victoria Lambert raised the firm’s price target on Fresenius Medical (FMS) to EUR 55 from EUR 47 and keeps a Buy rating on the shares.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMS:
- Fresenius Medical price target raised to $25 from $23 at Truist
- Fresenius Medical Care Rejoins DAX 40, Signifying Strategic Success
- Fresenius Medical Care Announces Release of Bond Guarantee
- Cara Therapeutics, Tvardi Therapeutics enter definitive merger agreement
- Fresenius Medical Care Resolves Legal Proceedings on Company Restructuring